STAT

Opinion: Pain doesn’t stigmatize people. We do that to each other

Millions of people who live with chronic pain experience stigma from health care providers, intimate partners, insurers, and others. That needs to end.

In 2000, a truck rear-ended my friend Andrea’s car as she stopped at a crosswalk in a school zone. The truck was going at least 45 miles per hour when it slammed into her. The accident damaged muscles, nerves, and bones from the base of her skull to the bottom of her left leg. It left her with an injured spine, pelvic instability, and significant leg injuries. She has been living with chronic pain ever since.

Andrea rarely takes opioids; she says they make her feel incredibly drowsy and often don’t work well to control her pain.

Yet she frequently experiences intense stigma when seeking care for her pain. Health care providers often regard her pain as a kind of personal weakness. Many of them have told her that “she doesn’t look like she is in pain.” She has lost count of the number of times she has been told

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
STAT1 min read
STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks